Case report {#sec1}
===========

A 74 year old man was diagnosed with a non-metastatic muscle-invasive transitional cell bladder carcinoma. He underwent a cysto-prostatectomy with an ileal conduit urinary diversion. The cysto-prostatectomy specimen showed transitional cell carcinoma extending into the perivesical tissue macroscopically (Pt3b stage), with lymphatic spread in 2 lymph nodes. Cisplatin-based adjuvant chemotherapy was conducted. Four months after surgery, the patient presented with multiple disseminated pigmented and flat skin lesions ([Fig. 1](#fig1){ref-type="fig"}).

CT scan revealed multiple subcutaneous nodules, as well as liver metastases and peritoneal carcinosis ([Fig. 2](#fig2){ref-type="fig"}).

A skin punch biopsy of a chest lesion was performed, showing features of poorly differentiated metastatic carcinoma. Immunohistochemical diagnosis showed cytokeratin p63 positive staining, confirming urothelial origin ([Fig. 3](#fig3){ref-type="fig"}).

Discussion {#sec2}
==========

Metastasic infiltration of the skin may occur due to direct tumor invasion, hematogenous or lymphatic spread, or as a result of iatrogenic implantation of tumor cells.[@bib1] Urinary bladder malignancies altogether account for 0.84% of cutaneous metastases.[@bib2], [@bib3] Diagnosis requires histological confirmation by microscopic examination of a skin biopsy.[@bib4] Prognosis of patients with bladder cancer cutaneous spread is generally poor with less than 1 year median survival.[@bib5] In addition to cisplatine-based chemotherapy, local skin radiation therapy may be also conducted.[@bib5]
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![Pigmented and flat skin lesion of the back.](gr1){#fig1}

![CT scan showing subcutaneous nodule extending to the anterior abdominal wall.](gr2){#fig2}

![Histology showing skin infiltration from an urothelial carcinoma with high positive immunohistochemical staining for P63.](gr3){#fig3}
